5,790 resources
By Version
By Realm
Start Prev Rows 3000 - 3200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Resource |
---|---|---|---|---|---|---|---|---|---|
ch.fhir.ig.ch-elm | R4 | ch-elm-observation-results-laboratory-susceptibility-strict | CH ELM Observation Results for Microbial susceptibility tests (strict) | active | 2025-06 | ch | Observation | ||
hl7.fhir.us.breast-radiology | R4 | CalcificationAbnormality | Calcification Abnormality | active | 2022-12 | us | Observation | ||
hl7.fhir.us.pacio-adi | R4 | ADI-CareExperiencePreference | ADI PtAuthored Care Experience Preference | trial-use | 2 | pe | 2025-07 | us | Observation |
hl7.eu.fhir.idea4rc | R4 | locoRegional-category | Observation: LocoRegional Category (Stage) | draft | 2025-07 | eu | Observation | ||
hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-category | TNM Distant Metastases Category Profile | active | 4 | cic | 2025-02 | us | Observation |
hl7.eu.fhir.idea4rc | R4 | mcode-tnm-distant-metastases-category | Observation: TNM Distant Metastases Category | draft | 2025-07 | eu | Observation | ||
hl7.eu.fhir.pcsp | R4 | mcode-tnm-distant-metastases-category | Observation: TNM Distant Metastases Category | draft | 2025-07 | eu | Observation | ||
hl7.eu.fhir.idea4rc | R4 | sarcoma-extent-category | Observation: Localized Category (Stage, Sarcoma) | draft | 2025-07 | eu | Observation | ||
hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-category | TNM Regional Nodes Category Profile | active | 4 | cic | 2025-02 | us | Observation |
hl7.eu.fhir.idea4rc | R4 | mcode-tnm-regional-nodes-category | Observation: TNM Regional Nodes Category | draft | 2025-07 | eu | Observation | ||
hl7.eu.fhir.pcsp | R4 | mcode-tnm-regional-nodes-category | Observation: TNM Regional Nodes Category | draft | 2025-07 | eu | Observation | ||
hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-category | TNM Primary Tumor Category Profile | active | 4 | cic | 2025-02 | us | Observation |
hl7.eu.fhir.idea4rc | R4 | mcode-tnm-primary-tumor-category | Observation: TNM Primary Tumor Category | draft | 2025-07 | eu | Observation | ||
hl7.eu.fhir.pcsp | R4 | mcode-tnm-primary-tumor-category | Observation: TNM Primary Tumor Category | draft | 2025-07 | eu | Observation | ||
hl7.fhir.cl.minsal.riap | R4 | riap-tnm-categoria-nodo-regional | Perfil de Categoria TNM Nodos Regional | draft | 1 | oo | 2025-04 | cl | Observation |
hl7.fhir.cl.minsal.riap | R4 | riap-tnm-categoria-tumor-primario | Perfil de Categoria TNM Tumor Primario | draft | 1 | oo | 2025-04 | cl | Observation |
hl7.fhir.cl.minsal.riap | R4 | riap-tnm-categoria-metastasis-distante | Perfil de Categoria TNM de Metástasis Distante | draft | 1 | oo | 2025-04 | cl | Observation |
nictiz.fhir.nl.r4.zib2020 | R4 | zib-Mobility.ChangingPosition | zib Mobility.ChangingPosition | draft | nl | Observation | |||
hl7.fhir.vn.core | R4 | observation-birth-height | Observation - Height at Birth profile | draft | 2025-07 | vn | Observation | ||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-Mobility.ClimbingStairs | zib Mobility.ClimbingStairs | draft | nl | Observation | |||
hl7.fhir.us.breastcancer | R3 | oncology-BreastClinicalLymphNodeInvolvement | BC BreastClinicalLymphNodeInvolvement Profile | draft | 2018-08 | us | Observation | ||
hl7.fhir.us.breastcancer | R3 | oncology-BreastPathologicalLymphNodeInvolvement | BC BreastPathologicalLymphNodeInvolvement Profile | draft | 2018-08 | us | Observation | ||
hl7.fhir.us.vr-common-library | R4 | coded-race-and-ethnicity-vr | Observation - Coded Race and Ethnicity Vital Records | active | pher | 2025-05 | us | Observation | |
hl7.fhir.uv.phd | R4 | PhdBaseObservation | PhdBaseObservation | trial-use | 1 | dev | 2017-11 | uv | Observation |
ch.fhir.ig.ch-elm | R4 | ch-elm-observation-component-conc | CH ELM Observation Component Results: Concentration | active | 2025-06 | ch | Observation | ||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-LivingSituation.LivingCondition | zib LivingSituation.LivingCondition | draft | nl | Observation | |||
hl7.fhir.us.breast-radiology | R4 | ConsistentWith | Consistent With | active | 2022-12 | us | Observation | ||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-AbilityToUseToilet.ToiletUse | zib AbilityToUseToilet.ToiletUse | draft | nl | Observation | |||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-AbilityToUseToilet.MenstrualCare | zib AbilityToUseToilet.MenstrualCare | draft | nl | Observation | |||
nictiz.fhir.nl.stu3.zib2015 | R3 | zib-VitalSigns | VitalSigns | retired | 2016-03 | nl | Observation | ||
hl7.fhir.us.breast-radiology | R4 | CystAbnormality | Cyst Abnormality | active | 2022-12 | us | Observation | ||
hl7.fhir.vn.core | R4 | observation-birth-weight | Observation - Weight at Birth profile | draft | 2025-07 | vn | Observation | ||
hl7.cda.us.ccdar2dot2 | R4 | 2.16.840.1.113883.10.20.6.2.13 | Code Observations | active | 2022-05 | us | Observation | ||
hl7.cda.us.ccdar2dot2 | R4 | 2.16.840.1.113883.10.20.6.2.12 | Text Observation | active | 2022-05 | us | Observation | ||
hl7.fhir.uv.dicom-sr | R5 | imaging-observation | Observation - DICOM SR Imaging Observation | active | ii | 2025-05 | uv | Observation | |
hl7.fhir.uv.dicom-sr | R5 | derived-imaging-measurement | Observation - DICOM SR Derived Imaging Measurement Mapping to Observation | active | ii | 2025-05 | uv | Observation | |
hl7.fhir.uv.dicom-sr | R5 | imaging-measurement-group | Observation - DICOM SR Imaging Measurement Group Mapping | active | ii | 2025-05 | uv | Observation | |
hl7.fhir.uv.dicom-sr | R5 | imaging-measurement | Observation - DICOM SR Imaging Measurement Mapping to Observation | active | ii | 2025-05 | uv | Observation | |
hl7.fhir.uv.dicom-sr | R5 | imaging-qualitative-evaluation | Observation - DICOM SR Imaging Qualitative Evaluation Mapping to Observation | active | ii | 2025-05 | uv | Observation | |
fhir.virtually.healthcare | R4 | Observation-Panel | Observation Panel | draft | 2025-07 | us | Observation | ||
fhir.nw-gmsa.nhs.uk | R4 | Observation | Observation | draft | 2025-04 | us | Observation | ||
fhir.nw-gmsa.nhs.uk | R4 | Observation-Panel | Observation Panel | draft | 2025-04 | us | Observation | ||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationvitalsigns | AT APS Observation Vital Signs | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observation | AT APS Observation | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationalcoholuse | AT APS Observation Alcohol Use | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationpregnancyedd | AT APS Observation Pregnancy Expected Delivery Date | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationpregnancyoutcome | AT APS Observation Pregnancy Outcome | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationpregnancystatus | AT APS Observation Pregnancy Status | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationresultslaboratorypathology | AT APS Observation Results Laboratory Pathology | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationresultsradiology | AT APS Observation Results Radiology | active | 2025-05 | Observation | |||
hl7.at.fhir.elga.aps.r4 | R4 | at-aps-observationtobaccouse | AT APS Observation Tobacco Use | active | 2025-05 | Observation | |||
hl7.fhir.us.vrdr | R4 | vrdr-surgery-date | Surgery Date | active | pher | 2024-10 | us | Observation | |
nictiz.fhir.nl.r4.zib2020 | R4 | zib-wounds.DateOfLastDressingChange | zib wounds.DateOfLastDressingChange | draft | nl | Observation | |||
hl7.fhir.us.vrdr | R4 | vrdr-decedent-disposition-method | Decedent Disposition Method | active | pher | 2024-10 | us | Observation | |
hl7.fhir.us.vrdr | R4 | vrdr-decedent-education-level | Decedent Education Level | active | pher | 2024-10 | us | Observation | |
hl7.fhir.us.vrdr | R4 | vrdr-decedent-military-service | Decedent Military Service | active | pher | 2024-10 | us | Observation | |
hl7.fhir.uv.shc-vaccination | R4 | shc-covid19-laboratory-result-observation-ad | COVID-19 Laboratory Result Observation Profile - Allowable Data | draft | pher | 2024-12 | uv | Observation | |
hl7.fhir.uv.shc-vaccination | R4 | shc-infectious-disease-laboratory-result-observation-ad | Generic Laboratory Result Observation Profile - Allowable Data | draft | pher | 2024-12 | uv | Observation | |
hl7.fhir.uv.shc-vaccination | R4 | shc-covid19-laboratory-result-observation-dm | COVID-19 Laboratory Result Observation Profile - Data Minimization | draft | pher | 2024-12 | uv | Observation | |
hl7.fhir.uv.shc-vaccination | R4 | shc-infectious-disease-laboratory-result-observation-dm | Generic Laboratory Result Observation Profile - Data Minimization | draft | pher | 2024-12 | uv | Observation | |
hl7.fhir.uv.mhealth-framework | R4 | mhealth-ade-observation | mHealth ADE Observation profile | active | 2020-04 | uv | Observation | ||
hl7.fhir.us.vdor | R4 | vdor-od-bystanders-present | VDOR Overdose - Bystander(s) Present | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-current-or-past-drug-misuse | VDOR Overdose - Current or Past Prescription Drug Misuse or Illicit Drug Use | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-evidence-of-drug-use | VDOR Overdose - Evidence of Drug Use | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-first-found-unresponsive | VDOR Overdose - Time/Date First Found Unresponsive | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-lnka | VDOR Overdose - Time/Date Last Known Alive and Well Pre-overdose | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-previous-overdose | VDOR Overdose - Previous Overdose | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-recent-emergency-department-visit | VDOR Overdose - Recent Emergency Department Visit or Urgent Care Visit | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-recent-opiod-use-relapse | VDOR Overdose - Recent Opiod Use Relapse | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-treatment-for-substance-use-disorder | VDOR Overdose - Treatment For Substance Use Disorder | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-type-of-overdose | VDOR Overdose - Type of Overdose/poisoning | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-od-use-of-prescription-morphine | VDOR Overdose - Use of Prescription Morphine | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-toxicology-summary-alcohol | VDOR Toxicology Summary Alcohol Tested Observation | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-toxicology-summary-carbon-monoxide | VDOR Toxicology Summary Carbon Monoxide Tested Observation | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.vdor | R4 | vdor-toxicology-summary | VDOR Toxicology Summary Observation | informative | pher | 2025-06 | us | Observation | |
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ObservationPersonalCharacteristic | SDOHCC Observation Personal Characteristic | trial-use | 2 | pc | 2025-05 | us | Observation |
uk.adsv2.r4 | R4 | UKCore-ADS-Pathways-Triage-Observation | UKCore ADS Pathways Triage Observation | draft | 2020-12 | Observation | |||
uk.adsv2.r4 | R4 | UKCore-ADS-SDSymptomDiscriminator-Triage-Observation | UKCore ADS SD (Symptom Discriminator) Triage Observation | draft | 2020-12 | Observation | |||
uk.adsv2.r4 | R4 | UKCore-ADS-SGSymptomGroup-Triage-Observation | UKCore ADS SG (Symptom Group) Triage Observation | draft | 2020-12 | Observation | |||
uk.adsv2.r4 | R4 | UKCore-ADS-AMPDS-Triage-Observation | UKCore ADS AMPDS Triage Observation | draft | 2020-12 | Observation | |||
hl7.fhir.uv.fhircast | R4 | fhircast-observation | FHIRcast Observation | trial-use | 4 | inm | 2025-07 | uv | Observation |
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-bodyheight-observation | CH RAD-Order Body Height Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-bodyheight-observation | CH eTOC Body Height Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-bodyweight-observation | CH RAD-Order Body Weight Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-bodyweight-observation | CH eTOC Body Weight Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-creatinineclearance-observation | CH RAD-Order Creatinine Clearance Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-creatinine-observation | CH RAD-Order Creatinine Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-expecteddeliverydate | CH eTOC Expected Delivery Date Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-INR-observation | CH RAD-Order INR Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-lab-observation | CH eTOC Lab Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-pathology-observation | CH eTOC Pathology Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-rad-order | R4 | ch-rad-order-platelets-observation | CH RAD-Order Platelets Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-pregnancystatus | CH eTOC Pregnancy Status Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-radiology-observation | CH eTOC Radiology Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-etoc | R4 | ch-etoc-cardiology-observation | CH eTOC Cardiology Observation | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hivaids | CH CRL Observation HIV/AIDS | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-annarborstaging | CH CRL Observation Ann Arbor Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-binetstaging | CH CRL Observation Binet Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-breslowthickness | CH CRL Observation Breslow Thickness | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cogallstaging | CH CRL Observation COG ALL Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cogstaging | CH CRL Observation COG Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-charlsonindex | CH CRL Observation Charlson Index | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-creasmangradingsystem | CH CRL Observation Creasman Grading System | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dssplus | CH CRL Observation DSSplus | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ebv | CH CRL Observation EBV | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-elstonellisgradingsystem | CH CRL Observation Elston/Ellis Grading System | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-figostaging | CH CRL Observation FIGO Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonbiopsymostcommongrade | CH CRL Observation Gleason Biopsy Most Common Grade | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonbiopsy2ndmostcommonorhighestgrade | CH CRL Observation Gleason Biopsy Second Most Common or Highest Grade | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonexcisionmostcommongrade | CH CRL Observation Gleason Excision Most Common Grade | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonexcision2ndmostcommonorhighestgrade | CH CRL Observation Gleason Excision Second Most Common or Highest Grade | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonscore | CH CRL Observation Gleason Score | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hpvp16 | CH CRL Observation HPV/p16 | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-her2receptorstatus | CH CRL Observation Her2 Receptor Status | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3code | CH CRL Observation ICCC-3 Code | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3extendedcode | CH CRL Observation ICCC-3 Extended Code | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3maingroup | CH CRL Observation ICCC-3 Main Group | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icd10 | CH CRL Observation ICD-10 | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3behaviour | CH CRL Observation ICD-O-3 Behaviour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3histologicalgrade | CH CRL Observation ICD-O-3 Histological Grade | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3laterality | CH CRL Observation ICD-O-3 Laterality | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphology | CH CRL Observation ICD-O-3 Morphology | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphologyposttransformation | CH CRL Observation ICD-O-3 Morphology Post-transformation | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphologypretransformation | CH CRL Observation ICD-O-3 Morphology Pre-transformation | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3topography | CH CRL Observation ICD-O-3 Topography | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-inrgssstaging | CH CRL Observation INRGSS Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-irssstaging | CH CRL Observation IRSS Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-issstaging | CH CRL Observation ISS Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ldh | CH CRL Observation LDH | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-luganostaging | CH CRL Observation Lugano Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pretextstaging | CH CRL Observation PRETEXT Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-raistaging | CH CRL Observation Rai Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-rhabdomyosarcomasitestaging | CH CRL Observation Rhabdomyosarcoma Site Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-siopstaging | CH CRL Observation SIOP Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-salzerkuntschikgradingsystem | CH CRL Observation SalzerKuntschik Grading System | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-shimadagradingsystem | CH CRL Observation Shimada Grading System | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-stjudemurphystaging | CH CRL Observation St. Jude / Murphy Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cm | CH CRL Observation cM | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ct | CH CRL Observation cT | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cn | CH CRL Observation cN | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pm | CH CRL Observation pM | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pt | CH CRL Observation pT | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pn | CH CRL Observation pN | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-tnmstagegroup | CH CRL Observation TNM Stage Group | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-torontotierIImanualstaging | CH CRL Observation Toronto Tier II (Manual) Staging | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-whogradegroup | CH CRL Observation WHO Grade Group | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-whocnsgradingsystem | CH CRL Observation WHO(CNS) Grading System | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-aprefixofptnm | CH CRL Observation a-Prefix of pTNM | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-associatedinsitutumour | CH CRL Observation Associated In-situ Tumour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cvaortia | CH CRL Observation Cerebrovascular Accident or Transient Ischemic Attack | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-chronicpulmonarydisease | CH CRL Observation Chronic Pulmonary Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-circumferentialresectionmargins | CH CRL Observation Circumferential Resection Margins | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-clinicaltumoursize | CH CRL Observation Clinical Tumour Size | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-congestiveheartfailure | CH CRL Observation Congestive Heart Failure | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-connectivetissuediseaserheumaticdisease | CH CRL Observation Connective Tissue Disease - Rheumatic Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dateofincidence | CH CRL Observation Date of Incidence | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dementia | CH CRL Observation Dementia | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-diabetesmellitus | CH CRL Observation Diabetes Mellitus | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hemiplegiaparaplegia | CH CRL Observation Hemiplegia / Paraplegia | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-liverdisease | CH CRL Observation Liver Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-lymphaticinvasion | CH CRL Observation Lymphatic Invasion | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-msuffixofpt | CH CRL Observation m-Suffix of pT | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-metastasesatdiagnosisindicator | CH CRL Observation Metastases at Diagnosis Indicator | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-microsatelliteinstability | CH CRL Observation Microsatellite Instability | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-moderatetoseverechronickidneydisease | CH CRL Observation Moderate to Severe Chronic Kidney Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-myocardialinfarction | CH CRL Observation Myocardial Infarction | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberexaminedregionallymphnodes | CH CRL Observation Number of Examined Regional Lymph Nodes | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberexaminedsentinellymphnodes | CH CRL Observation Number of Examined Sentinel Lymph Nodes | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberinvolvedregionallymphnodes | CH CRL Observation Number of Involved Regional Lymph Nodes | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberpositivesentinellymphnodes | CH CRL Observation Number of Positive Sentinel Lymph Nodes | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-oestrogenreceptorstatus | CH CRL Observation Oestrogen Receptor Status | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pathologicaltumoursize | CH CRL Observation Pathological Tumour Size | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pepticulcerdisease | CH CRL Observation Peptic Ulcer Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-perineuralinvasion | CH CRL Observation Perineural Invasion | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-peripheralvasculardisease | CH CRL Observation Peripheral Vascular Disease | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pretreatmentprostatespecificantigen | CH CRL Observation Pretreatment Prostate Specific Antigen | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-progesteronereceptorstatus | CH CRL Observation Progesterone Receptor Status | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-resectionmargininsitutumour | CH CRL Observation Resection Margin In-situ Tumour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-resectionmargininvasivetumour | CH CRL Observation Resection Margin Invasive Tumour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-residualinsitutumour | CH CRL Observation Residual In-situ Tumour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-residualinvasivetumour | CH CRL Observation Residual Invasive Tumour | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-sentinellymphnodeassessment | CH CRL Observation Sentinel Lymph Node Assessment | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-serumtumourmarkers | CH CRL Observation Serum Tumour Markers | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-topographymetastasesatdiagnosis | CH CRL Observation Topography of Metastases at Diagnosis | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-topographypostdiagnosismetastases | CH CRL Observation Topography of Post-diagnosis Metastases | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-tumourproliferationlabeling | CH CRL Observation Tumour Proliferation Labeling | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-typerecurrencetransformation | CH CRL Observation Type of Recurrence/Transformation | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-venousinvasion | CH CRL Observation Venous Invasion | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-yprefixofctnm | CH CRL Observation y-Prefix of cTNM | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-yprefixofptnm | CH CRL Observation y-Prefix of pTNM | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-alphafetoprotein | CH CRL Observation α-fetoprotein | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hcg | CH CRL Observation β-hCG | active | 2022-02 | ch | Observation | ||
ch.fhir.ig.ch-vacd | R4 | ch-vacd-laboratory-serology | CH VACD Laboratory And Serology | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-emed | R4 | ch-emed-observation-list | CH EMED Observation (LIST) | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation-list | PML Observation | draft | 2025-01 | ch | Observation | ||
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation-body-weight | Body Weight Observation | draft | 2025-01 | ch | Observation | ||
ch.fhir.ig.ch-emed | R4 | ch-emed-observation | CH EMED Observation (PADV) | active | 2025-05 | ch | Observation | ||
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation | PADV Observation | draft | 2025-01 | ch | Observation | ||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-DevelopmentChild.ToiletTrainednessFeces | zib DevelopmentChild.ToiletTrainednessFeces | draft | nl | Observation | |||
nictiz.fhir.nl.r4.zib2020 | R4 | zib-DevelopmentChild.ToiletTrainednessUrine | zib DevelopmentChild.ToiletTrainednessUrine | draft | nl | Observation |